Cholecystectomy and the risk of esophageal and gastric cancer

Saudi Medical Journal

Volumn 33, Issue 10, 2012, Pages 1073-1079

  Ge, Zhenming ^a   Zhao, Chengjin ^a   Wang, Yamin ^a   Qian, Junbo ^a  

^a First People's Hospital of Nantong   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHOLECYSTECTOMY; COHORT ANALYSIS; CONTROLLED STUDY; DATA EXTRACTION; DATA SYNTHESIS; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; GENETIC HETEROGENEITY; HUMAN; MEDICAL RECORD REVIEW; META ANALYSIS; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STANDARDIZED MORTALITY RATIO; STOMACH CANCER;

CASE-CONTROL STUDIES; CHOLECYSTECTOMY; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; HUMANS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84871910013     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
3. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009; 24: 729-735.
4. Cook MB, Chow WH, Devesa SS. Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 2009; 101: 855-859.
5. Steevens J, Botterweck AA, Dirx MJ, van den Brandt PA, Schouten LJ. Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 2010; 22: 669-678.
6. Pandeya N, Williams GM, Sadhegi S, Green AC, Webb PM, Whiteman DC. Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esophagus. Am J Epidemiol 2008; 168: 105-114.
7. Nason KS, Wichienkuer PP, Awais O, Schuchert MJ, Luketich JD, O'Rourke RW, et al. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis. Arch Surg 2011; 146: 851-858.
8. Quiros RM, Bui CL. Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 2009; 89: 79-96.
9. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19: 689-701.
10. Yang WG, Chen CB, Wang ZX, Liu YP, Wen XY, Zhang SF, et al. A case-control study on the relationship between salt intake and salty taste and risk of gastric cancer. World J Gastroenterol 2011; 17: 2049-2053.
11. Kim HJ, Lim SY, Lee JS, Park S, Shin A, Choi BY, et al. Fresh and pickled vegetable consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci 2010; 101: 508-516.
12. Nakao M, Matsuo K, Ito H, Shitara K, Hosono S, Watanabe M, et al. ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection. Cancer Epidemiol Biomarkers Prev 2011; 20: 1665-1672.
13. Goldacre MJ, Abisgold JD, Seagroatt V, Yeates D. Cancer after cholecystectomy: record-linkage cohort study. Br J Cancer 2005; 92: 1307-1309.
14. Fall K, Ye W, Nyrén O. Risk for gastric cancer after cholecystectomy. Am J Gastroenterol 2007; 102: 1180-1184.
15. Lagergren J, Mattsson F. Cholecystectomy as a risk factor for oesophageal adenocarcinoma. Br J Surg 2011; 98: 1133-1137.
16. Chan JM, Wang F, Holly EA. Pancreatic cancer, animal protein and dietary fat in a population-based study, San Francisco Bay Area, California. Cancer Causes Control 2007; 18: 1153-1167.
17. Siddiqui AA, Kedika R, Mahgoub A, Patel M, Cipher DJ, Bapat V. A previous cholecystectomy increases the risk of developing advanced adenomas of the colon. South Med J 2009; 102: 1111-1115.
18. Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol 2005; 100: 1813-1820.
19. Reid FD, Mercer PM, Harrison M, Bates T. Cholecystectomy as a risk factor for colorectal cancer: a meta-analysis. Scand J Gastroenterol 1996; 31: 160-169.
20. Fein M, Bueter M, Sailer M, Fuchs KH. Effect of cholecystectomy on gastric and esophageal bile reflux in patients with upper gastrointestinal symptoms. Dig Dis Sci 2008; 53: 1186-1191.
21. Atak I, Ozdil K, Yücel M, Caliskan M, Kilic A, Erdem H, et al. The effect of laparoscopic cholecystectomy on the development of alkaline reflux gastritis and intestinal metaplasia. Hepatogastroenterology 2012; 59: 59-61.
22. Kono K, Takahashi A, Sugai H, Iizuka H, Fujii H. Trypsin activity and bile acid concentrations in the esophagus after distal gastrectomy. Dig Dis Sci 2006; 51: 1159-1164.
23. Kawabe A, Shimada Y, Soma T, Maeda M, Itami A, Kaganoi J, et al. Production of prostaglandinE2 via bile acid is enhanced by trypsin and acid in normal human esophageal epithelial cells. Life Sci 2004; 75: 21-34.
24. Gustavsson S, Adami HO, Meirik O, Nyrén O, Krusemo UB. Cholecystectomy as a risk factor for gastric cancer. A cohort study. Dig Dis Sci 1984; 29: 116-120.
25. Ichimiya H, Kono S, Ikeda M, Tokudome S, Nakayama F, Kuratsune M. Cancer mortality among patients undergoing cholecystectomy for benign biliary diseases. Jpn J Cancer Res 1986; 77: 579-583.
26. Sarli L, Gafa M, Lupi M, Sansebastiano G, Longinotti E, Peracchia A. Gallstones and gastric cancer: a matched casecontrol study. World J Surg 1986; 10: 884-891.
27. Freedman J, Lagergren J, Bergström R, Näslund E, Nyrén O. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg 2000; 87: 1087-1093.
28. Freedman J, Ye W, Näslund E, Lagergren J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology 2001; 121: 548-553.
29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7: 177-188.
30. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
32. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993; 105: 130-141.
33. Fracchia M, Galatola G, Sarotto I, Guraldo V, Perona M, Pera A, et al. Serum bile acids, programmed cell death and cell proliferation in the mucosa of patients with colorectal adenomas. Dig Liver Dis 2005; 37: 509-514.
34. Berta L, Fronticelli Baldelli C, Fazzari A, Radice E, Bargoni A, Frairia R, et al. Sex steroid receptors, secondary bile acids and colorectal cancer. A possible mechanism of interaction. A possible mechanism of interaction. Panminerva Med 2003; 45: 261-266.
35. Ahnen DJ, Guerciolini R, Hauptman J, Blotner S, Woods CJ, Wargovich MJ. Effect of orlistat on fecal fat, fecal biliary acids, and colonic cell proliferation in obese subjects. Clin Gastroenterol Hepatol 2007; 5: 1291-1299.
36. Kunsch S, Neesse A, Huth J, Steinkamp M, Klaus J, Adler G, et al. Increased Duodeno-Gastro-Esophageal Reflux (DGER) in symptomatic GERD patients with a history of cholecystectomy. Z Gastroenterol 2009; 47: 744-748.
37. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831.
38. Bredenoord AJ. Mechanisms of reflux perception in gastroesophageal reflux disease: a review. Am J Gastroenterol 2012; 107: 8-15.
39. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 872-878.
40. Persson GE, Ros AG, Thulin AJ. Surgical treatment of gallstones: changes in a defined population during a 20-year period. Eur J Surg 2002; 168: 13-17.